contact us Contact Us Or call +44 (0)118 979 1169
  • About
    • Who are GRA?
    • Meet Lee
    • Associates
    • Testimonials
    • FAQs
  • Services
    • Biotech Consulting
    • Biotech Speaker
    • Training
  • Blog
  • Contact Us
  • Case Studies
  • Resources
    • Articles
    • Videos
    • Presentations
    • Free Templates
    • Newsletters
  • Search
  • Client Login
    • Trello
    • GoToMeeting
    • join me
  • Services
  • Biotech Consulting
    • Regulatory Affairs (RA)
    • Quality by Design (QbD)
    • Formulation Development
    • Vaccine Development
    • Process Characterization
    • Cell & Seed Bank Characterization
    • CMC
    • Commercial Support
    • Biotech Due Diligence
    • Product Characterisation
    • CMO Management
    • Licencing
    • Design of Experiments (DoE)
    • Process Validation
    • Analytical Development
  • Biotech Speaker
  • Training

Vaccine Development

Vaccine Development consulting

Vaccines are arguably one of the best value medicines available to governments and national bodies in preventing rather than treating disease.   Vaccine Development is an activity that GRA identifies as a core area of expertise.   GRA has worked on a wide array of areas in the development of vaccines that include activities including discovery, R&D, process development, assay development and regulatory interactions with agencies.  Vaccines come in many forms – viral, bacterial, live attenuated, inactivated, VLP, recombinant and vector based.  All have their own idiosyncrasies & requirements to become a successful products.   Given the complexity of vaccines and their interaction with the immune system, appropriate assay development is a critical component of measuring vaccine potency, whether in the vial or the immune response from the patient.  GRA has many years experience of helping in the development of vaccine potency assays that include: TCID50, plaque based assays, immunofocus assays, flow cytometric assays, QPCR assays and ELISAs,

GRA has worked with a number of companies in the development of vaccines including Takeda Vaccines, FluGen & Themis Biosciences.  Our experience covers viral, bacterial, live attenuated, inactivated, VLP, recombinant and vector based products.  Diseases that GRA have experience of include:

  • Dengue Fever
  • Zika virus
  • Influenza
  • Enterovirus 71 (EV71 – Hand, Foot & Mouth)
  • Typhoid
  • Measles
  • Meningitis B
  • Hepatitis B
  • Chikungunya
  • Enterotoxigenic E. coli
  • Group B Streptococcus (GBS)
  • Anthrax
  • Herpes Simplex Virus I/II (HSV)
  • Japanese encephalitis

 

  • need to get in touch? Contact GRA Email GRA +44 (0) 118 979 1169
  • Stay up
    to date

    Complete your details and we’ll send you regular updates via our newsletter.

  • Our newsletter



    • Resources

      Need to understand some element of the biopharma industry or looking for a particular template?

      Click here to see our free resources

    • About
      • Who are GRA?
      • Meet Lee
      • Associates
      • Testimonials
      • FAQs
    • Services
      • Biotech Consulting
      • Biotech Speaker
      • Training
    • Blog
    • Contact Us
    • Case Studies
    • Resources
      • Articles
      • Videos
      • Presentations
      • Free Templates
      • Newsletters
    Terms & Conditions Privacy Policy Cookies FAQs

    © 2023 GreyRigge Associates Limited. All rights reserved.

    Site design & build by Hinge Ltd.